Vidcast: https://youtu.be/GGrGBx1kY7I
Let’s review some the healthcare-related business news for this rd week of May, 2022
Google and DeepMind, Alphabet’s AI lab subsidiary, are facing a British lawsuit for their use of confidential health information belonging to 1.6 million users of the UK’s National Health System. The data was mined from a smartphone app called “Streams” that dealt with kidney problems. It’s not the first time for these defendants either as they and the University of Chicago were the targets of a class-action lawsuit for patient privacy violations.
https://www.healthcareitnews.com/news/emea/google-and-deepmind-face-legal-claim-unauthorised-use-nhs-medical-records
Gilead, the maker of the HIV PreP drugs Truvada and Descovy, has partially settled their suit against 58 defendants for illegally selling drugs provided as part of Gilead’s charity program providing medications for those unable to afford them. Shady clinics and pharmacies defrauded the program of more than $68 million over less than 2 years, and their owners were caught purchasing mansions, cryptocurrency, jewelry, sports cars, and private jets. Shameful.
https://www.medscape.com/viewarticle/974065
Pfizer and United Healthcare are two of the largest donors to legislators who are pushing to rob women of their reproductive choices. An investigative report by Insider details the nearly 1,000 healthcare companies including insurers, medical associations, drug companies, clinics, pharmacies, and care facilities that have in toto donated more than $10 million to 380 state legislators and 13 governors who enacted anti-choice laws. It is disgusting that companies and organizations dedicated to excellent healthcare for all are taking sides in this frankly stupid culture war to deny women their rightful reproductive choices.
https://www.businessinsider.com/healthcare-corporations-and-pharma-give-big-to-anti-abortion-movement-2022-5
Alife Health, a San Francisco startup, that is creating AI tools to guide more successful in-vitro fertilization, has just scored $22 million in Series A financing from the VC firms of Lux Capital, Union Square Ventures, and Maveron. The company’s first product, Stim Assist, provides guidance about the optimal times for ovarian drug stimulation necessary to procure mature eggs ripe for fertilization. A second product in the pipeline, Embryo Predict, helps to evaluate available embryos and pinpoint the best ones to transfer. A patient app, also in development, will provide a digital framework for care reminders and educational tools.
https://healthcareweekly.com/a-california-start-up-uses-ai-to-improve-fertility-care-and-adapt-it-to-each-patient/
There you have the latest healthcare-related business news for this 3rd week of May, 2022